Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs oxycodone vs placebo for postoperative pain after laparoscopic total hysterectomy
ChiCTR2600126560Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in acute pain (3 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: SPID24 at rest (0–24h). Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2600126560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126560.